Celldex Therapeutics (CLDX)
9.22 x 24 24.05 x 1
Pre-market by (Cboe BZX)
15.13 -0.60 (-3.81%) 04/08/25 [NASDAQ]
9.22 x 24 24.05 x 1
Pre-market 15.20 +0.07 (+0.46%) 05:09 ET
for Tue, Apr 8th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -157,863 | -141,429 | -112,325 | -70,511 | -59,780 |
| Depreciation Amortization | -12,572 | -3,214 | 3,740 | 3,359 | 21,200 |
| Accounts receivable | 1,928 | -2,281 | -175 | 1,574 | -787 |
| Other Working Capital | -21,601 | 13,462 | -3,898 | -1,054 | -299 |
| Other Operating Activity | 32,330 | 26,171 | 8,926 | 5,723 | -738 |
| Operating Cash Flow | $-157,778 | $-107,291 | $-103,732 | $-60,909 | $-40,404 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -288,210 | -103,964 | 91,701 | -214,934 | -96,721 |
| PPE Investments | -1,919 | -1,818 | -1,759 | -1,222 | -1,497 |
| Investing Cash Flow | $-290,129 | $-105,782 | $89,942 | $-216,156 | $-98,218 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 2,962 |
| Debt Repayment | N/A | N/A | N/A | N/A | -2,962 |
| Common Stock Issued | 441,449 | 218,458 | 4,076 | 272,372 | 171,226 |
| Financing Cash Flow | $441,449 | $218,458 | $4,076 | $272,372 | $171,226 |
| Beginning Cash Position | 34,814 | 29,429 | 39,143 | 43,836 | 11,232 |
| End Cash Position | 28,356 | 34,814 | 29,429 | 39,143 | 43,836 |
| Net Cash Flow | $-6,458 | $5,385 | $-9,714 | $-4,693 | $32,604 |
| Free Cash Flow | |||||
| Operating Cash Flow | -157,778 | -107,291 | -103,732 | -60,909 | -40,404 |
| Capital Expenditure | -1,919 | -1,818 | -1,828 | -1,249 | -1,552 |
| Free Cash Flow | -159,697 | -109,109 | -105,560 | -62,158 | -41,956 |